Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. SPCX
7. AVGO
8. HD
9. BJ
10. BABA

Go back to Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.94 +0.52 (6.18%)
Previous Close $8.42    52 Week High $9.23 
Open $8.44    52 Week Low $1.16 
Day High $9.20    P/E N/A 
Day Low $8.44    EPS $-0.30 
Volume 10,440,294